Advisory Board Member Profile 2017
Director FCPA Data Analysis and Analytics, Global Risk, Compliance & Controls FCPA Center Excellence
Areas of Expertise
Data Analytics for Finance & HR; Reducing Risk Through Big Data
Design and implement global strategies, tools, methodologies and maximize big data analysis to ensure compliance with FCPA and other Anti-bribery and Anti-Corruption regulations across the globe.
In charge of develop a unified information, methodologies and tools architecture that enables to leverage all types of data (big and small), used in ingenious ways to ensure compliance, detect risks, and react promptly to events and changes in business conditions.
As member of the Pfizer’s FCPA Center of Excellence, me and my team will be focused on the design of Data architecture that promotes a unified vision for information management and analytics, develop methodologies, implement tools and establish global procedures in order to reveal patterns, trends, and associations, relating to interactions at the market level and ensure FCPA compliance.
Support the execution of GRCC strategy, goals, and activities of the FCPA Center of Excellence function globally to facilitate risk identification and control monitoring activities providing pan-Pfizer updates to stakeholders on FCPA activities, key risks, issues, trends, and action plans.
Promote awareness of compliance and controls while driving a strong culture that supports all Global Risk, Compliance and Controls initiatives.
Set best compliance practices in the industry.
Acted as a speaker at the Anti-bribery and Fraud Prevention Latin American summit in 2011.
Invited to support 2 Pfizer's subsidiaries (Algeria and South Africa) to design their Anti-corruption program with proven positive results.
Specialties: FCPA, SOX, Business Continuity Management, Compliance, Corporate Audit, Corporate Governance, Risk Assurance, US Gaap, IFRS,